Robeco Institutional Asset Management B.V. Bristol Myers Squibb CO Transaction History

Robeco Institutional Asset Management B.V.

$60.3 Billion
Q2 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 6,401,401 shares of BMY stock, worth $313 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

6,401,401

Previous 4,387,326 45.91%

Holding current value

$313 Million

Previous $268 Million 10.74%

% of portfolio

0.49%

Previous 0.53%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$44.12 - $59.6 $88.9 Million - $120 Million	2,014,075 Added 45.91%	6,401,401 $296 Million
Q1 2025 Apr 23, 2025	BUY	$53.9 - $63.11 $478,578 - $560,353	8,879 Added 0.2%	4,387,326 $268 Million
Q4 2024 Jan 22, 2025	SELL	$51.92 - $59.94 $1.64 Million - $1.9 Million	-31,624 Reduced 0.72%	4,378,447 $248 Million
Q3 2024 Oct 29, 2024	BUY	$39.66 - $51.75 $4.34 Million - $5.67 Million	109,503 Added 2.55%	4,410,071 $228 Million
Q2 2024 Jul 22, 2024	BUY	$40.25 - $52.99 $48 Million - $63.3 Million	1,193,731 Added 38.42%	4,300,568 $179 Million
Q1 2024 Apr 24, 2024	SELL	$47.98 - $54.4 $39 Million - $44.2 Million	-812,697 Reduced 20.73%	3,106,837 $168 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $93.1 Million - $111 Million	1,920,702 Added 96.09%	3,919,534 $201 Million
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $93.6 Million - $112 Million	-1,929,827 Reduced 49.12%	1,998,832 $3.92 Billion
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $1.27 Million - $1.42 Million	-21,866 Reduced 0.55%	3,928,659 $228 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $12.2 Million - $13.6 Million	-191,681 Reduced 4.63%	3,950,525 $253 Million
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $9.86 Million - $11.2 Million	150,126 Added 3.76%	4,142,206 $287 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $6.95 Million - $8.23 Million	-101,451 Reduced 2.48%	3,992,080 $287 Million
Q3 2022 Dec 01, 2022	BUY	$0.13 - $76.84 $156,056 - $92.2 Million	1,200,434 Added 41.49%	4,093,531 $291 Million
Q3 2022 Oct 26, 2022	BUY	$0.13 - $76.84 $156,056 - $92.2 Million	1,200,434 Added 41.49%	4,093,531 $291 Million
Q2 2022 Dec 01, 2022	BUY	$72.62 - $79.98 $34.6 Million - $38.1 Million	476,440 Added 19.71%	2,893,097 $223 Million
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $34.6 Million - $38.1 Million	476,440 Added 19.71%	2,893,097 $223 Million
Q1 2022 Dec 01, 2022	SELL	$61.48 - $73.72 $1.91 Million - $2.3 Million	-31,133 Reduced 1.27%	2,416,657 $176 Million
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $1.91 Million - $2.3 Million	-31,133 Reduced 1.27%	2,416,657 $176 Million
Q4 2021 Dec 01, 2022	BUY	$53.63 - $62.52 $4.44 Million - $5.18 Million	82,857 Added 3.5%	2,447,790 $153 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $4.44 Million - $5.18 Million	82,857 Added 3.5%	2,447,790 $153 Million
Q3 2021 Dec 01, 2022	BUY	$59.17 - $69.31 $13.7 Million - $16 Million	231,523 Added 10.85%	2,364,933 $140 Million
Q3 2021 Oct 20, 2021	BUY	$59.17 - $69.31 $13.7 Million - $16 Million	231,523 Added 10.85%	2,364,933 $140 Million
Q2 2021 Dec 01, 2022	BUY	$61.91 - $67.42 $50.7 Million - $55.2 Million	818,609 Added 62.26%	2,133,410 $143 Million
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $50.7 Million - $55.2 Million	818,609 Added 62.26%	2,133,410 $143 Million
Q1 2021 Dec 01, 2022	SELL	$59.34 - $66.74 $165 Million - $185 Million	-2,778,730 Reduced 67.88%	1,314,801 $83 Million
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $35.7 Million - $40.2 Million	602,256 Added 84.52%	1,314,801 $83 Million
Q4 2020 Dec 01, 2022	SELL	$57.74 - $65.43 $195 Million - $221 Million	-3,380,986 Reduced 82.59%	712,545 $44.2 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $10.1 Million - $11.4 Million	-174,867 Reduced 19.71%	712,545 $44.2 Million
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $2.11 Million - $2.34 Million	36,795 Added 4.33%	887,412 $53.5 Million
Q2 2020 Jul 20, 2020	SELL	$54.82 - $64.09 $1.05 Million - $1.23 Million	-19,222 Reduced 2.21%	850,617 $50 Million
Q1 2020 Apr 30, 2020	BUY	$46.4 - $67.43 $3.3 Million - $4.79 Million	71,029 Added 8.89%	869,839 $48.5 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $7.05 Million - $9.19 Million	143,204 Added 21.84%	798,810 $51.3 Million
Q3 2019 Oct 17, 2019	SELL	$42.77 - $50.71 $91,656 - $108,671	-2,143 Reduced 0.33%	655,606 $33.2 Million
Q2 2019 Jul 19, 2019	SELL	$44.62 - $49.34 $319,300 - $353,077	-7,156 Reduced 1.08%	657,749 $29.8 Million
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $1.1 Million - $1.32 Million	24,465 Added 3.82%	664,905 $31.7 Million
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $4.15 Million - $5.38 Million	85,121 Added 15.33%	640,440 $33.2 Million
Q3 2018 Oct 31, 2018	BUY	$55.19 - $62.25 $77,928 - $87,897	1,412 Added 0.25%	555,319 $34.5 Million
Q3 2018 Oct 25, 2018	BUY	$55.19 - $62.25 $4.97 Million - $5.6 Million	89,966 Added 19.39%	553,907 $34.4 Million
Q2 2018 Aug 03, 2018	BUY	$50.53 - $62.98 $2.25 Million - $2.81 Million	44,562 Added 10.63%	463,941 $25.7 Million
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $4.1 Million - $4.72 Million	68,388 Added 19.48%	419,379 $26.5 Million
Q4 2017 Jan 25, 2018	BUY	$59.94 - $65.35 $15.2 Million - $16.6 Million	253,871 Added 261.4%	350,991 $21.5 Million
Q3 2017 Oct 17, 2017	SELL	$55.23 - $63.74 $376,226 - $434,196	-6,812 Reduced 6.55%	97,120 $6.19 Million
Q2 2017 Aug 08, 2017	BUY	N/A	27,041 Added 35.17%	103,932 $5.79 Million
Q1 2017 Jan 19, 2021	BUY	N/A	76,891	76,891 $4.18 Million

Others Institutions Holding BMY

# of Institutions

2,743

Shares Held

1.59B

Call Options Held

25.8M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Bristol Myers Squibb CO Transaction History